Meet the FierceBiotech Fierce 15 next week

Arsalan Arif, Publisher
Follow me on twitter

Next week our sister publication FierceBiotech unveils its Fierce 15, our most anticipated feature of the year. FierceBiotech's veteran news team--led by John Carroll and Ryan McBride--assembled our best class yet of private biotechs pushing the innovation we're privileged to cover. We can't wait to share it with our readers.

To be the first to know:

  • Visit FierceBiotech at 9:00AM ET on Tuesday, September 6
  • Follow @FierceBiotech on twitter
  • Subscribe to FierceBiotech if you haven't already, or send the link to a colleague

And to be the first to meet a few of our winners in person, attend BioPharm America 2011 in Boston. The meeting starts in just a few short days. (Direct registration link here.) Several Fierce 15 CEOs will take questions from John Carroll in a unique "Fierce 15 Revealed" session on Sept. 7 at BioPharm America 2011, which is produced by EBD Group. We've long collaborated on successful projects with EBD Group serving the biotech and pharma dealmaking communities.

They also know how to throw a party. I'll be there with John and Ryan and hope to see you there, too.

Thanks for being part of the Fierce community.

- Arsalan Arif, Group Publisher
Questions? Ideas? E-mail me

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.